OsimertinibAcquired resistance to osimertinib leading to transformation of lung adenocarcinoma to small cell lung carcinoma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1654卷 / 1期

关键词：

D O I：

10.1007/s40278-017-30998-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：265 / 265

相关论文

共 50 条

[1] OsimertinibAcquired resistance to osimertinib therapy in lung adenocarcinoma: case report
Reactions Weekly, 2018, 1718 (1) : 176 - 176
[2] OsimertinibAcquired resistance in lung adenocarcinoma: case report
Reactions Weekly, 2019, 1735 (1) : 205 - 205
[3] AlectinibAcquired resistance leading to small cell lung carcinoma transformation: case report
Reactions Weekly, 2016, 1620 (1) : 16 - 16
[4] PembrolizumabDrug resistance and transformation of adenocarcinoma to small cell lung carcinoma: case report
Reactions Weekly, 2020, 1828 (1) : 410 - 410
[5] Gefitinib/osimertinibAcquired resistance in lung adenocarcinoma: case report
Reactions Weekly, 2018, 1713 (1) : 177 - 177
[6] Gefitinib/osimertinibAcquired drug resistance and transformation to small cell lung cancer: case report
Reactions Weekly, 2020, 1804 (1) : 134 - 134
[7] Afatinib resistanceDevelopment of resistance as a transformation of lung adenocarcinoma to small cell carcinoma carcinoma: case report
Reactions Weekly, 2017, 1672 (1) : 16 - 16
[8] OsimertinibAcquired resistance and transformation of non-small cell lung cancer to large-cell neuroendocrine carcinoma: case report
Reactions Weekly, 2021, 1848 (1) : 314 - 314
[9] Transformation of lung adenocarcinoma to small cell lung cancer following osimertinib treatment: a case report and literature review
Kuang, Linwu
Wang, Peng
Zhou, Lin
Li, Yangkai
ANTI-CANCER DRUGS, 2025, 36 (03) : 253 - 259
[10] GefitinibDevelopment of resistance to gefitinib resulting in transformation of adenocarcinoma to small cell lung carcinoma : case report
Reactions Weekly, 2018, 1698 (1) : 172 - 172

← 1 2 3 4 5 →